CY1111602T1 - ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ - Google Patents

ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ

Info

Publication number
CY1111602T1
CY1111602T1 CY20101101006T CY101101006T CY1111602T1 CY 1111602 T1 CY1111602 T1 CY 1111602T1 CY 20101101006 T CY20101101006 T CY 20101101006T CY 101101006 T CY101101006 T CY 101101006T CY 1111602 T1 CY1111602 T1 CY 1111602T1
Authority
CY
Cyprus
Prior art keywords
neurotrypsin
activity
diagnosis
detection
vivo
Prior art date
Application number
CY20101101006T
Other languages
English (en)
Inventor
Peter Sonderegger
Stefan Hettwer
Alexander Stephan
Kazumasa Miyai
Beat Kunz
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotune Ag filed Critical Neurotune Ag
Publication of CY1111602T1 publication Critical patent/CY1111602T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Μέθοδος για την ανίχνευση της δραστικότητας in vivo της νευροτρυψίνης, όπου η ποσότητα του C-τερματικού 22-kDa θραύσματος της αγρίνης μετριέται σε ένα δείγμα, το οποίο λαμβάνεται από έναν ασθενή και η μετρηθείσα ποσότητα 22-kDa θραύσματος της αγρίνης εις το δείγμα χρησιμοποιείται για να υπολογισθεί η δραστικότητα της νευροτρυψίνης, χρήση της μεθόδου για την διάγνωση και παρακολούθηση διαταραχών, οι οποίες σχετίζονται με την νευροτρυψίνη και χρήση του 22-kDa θραύσματος της αγρίνης ως βιοδείκτη για διαταραχές, οι οποίες σχετίζονται με την νευροτρυψίνη.
CY20101101006T 2007-05-10 2010-11-08 ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ CY1111602T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07009398A EP1990420B1 (en) 2007-05-10 2007-05-10 Method for the detection of the in-vivo activity of neurotrypsin, use of the method and use of the C-terminal 22-kDa fragment of agrin as biomarker in diagnosis and monitoring of neurotrypsin-related disturbances

Publications (1)

Publication Number Publication Date
CY1111602T1 true CY1111602T1 (el) 2015-10-07

Family

ID=38180345

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101006T CY1111602T1 (el) 2007-05-10 2010-11-08 ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ

Country Status (16)

Country Link
US (1) US20100240083A1 (el)
EP (1) EP1990420B1 (el)
JP (1) JP2010526994A (el)
CN (1) CN101680022A (el)
AT (1) ATE477329T1 (el)
AU (1) AU2008250733A1 (el)
BR (1) BRPI0811429A2 (el)
CA (1) CA2692132A1 (el)
CY (1) CY1111602T1 (el)
DE (1) DE602007008370D1 (el)
DK (1) DK1990420T3 (el)
ES (1) ES2350254T3 (el)
PL (1) PL1990420T3 (el)
PT (1) PT1990420E (el)
SI (1) SI1990420T1 (el)
WO (1) WO2008138474A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2484695A1 (en) 2011-02-04 2012-08-08 Neurotune AG A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human C44-fragment of agrin
EP2631657A1 (en) * 2012-02-25 2013-08-28 Neurotune AG Immunoassay for the detection of the 22kDa C-terminal fragment (CAF) of agrin
US20160274126A1 (en) * 2012-11-13 2016-09-22 William Beaumont Hospital Biomarkers for the diagnosis of interstitial cystitis
US11815515B2 (en) * 2018-01-17 2023-11-14 University Of Southampton Methods to predict risk of and to stratify sarcopenia and NAD deficiency
US11564983B1 (en) * 2021-08-20 2023-01-31 Betagen Scientific Limited Efficient expression system of SARS-CoV-2 receptor binding domain (RBD), methods for purification and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101193858B (zh) * 2005-03-30 2012-01-04 苏黎世大学 神经蛋白酶抑制剂及其确定
US20100095387A1 (en) * 2005-07-15 2010-04-15 Martin Smith Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases

Also Published As

Publication number Publication date
WO2008138474A1 (en) 2008-11-20
SI1990420T1 (sl) 2010-12-31
ES2350254T3 (es) 2011-01-20
CA2692132A1 (en) 2008-11-20
BRPI0811429A2 (pt) 2016-05-17
DE602007008370D1 (de) 2010-09-23
PL1990420T3 (pl) 2011-01-31
PT1990420E (pt) 2010-11-04
EP1990420A1 (en) 2008-11-12
US20100240083A1 (en) 2010-09-23
EP1990420B1 (en) 2010-08-11
DK1990420T3 (da) 2010-11-15
CN101680022A (zh) 2010-03-24
AU2008250733A1 (en) 2008-11-20
JP2010526994A (ja) 2010-08-05
ATE477329T1 (de) 2010-08-15

Similar Documents

Publication Publication Date Title
GB201116860D0 (en) Patent monitoring method and monitoring device
ATE554389T1 (de) Apex als marker für lungenkrebs
ATE473030T1 (de) Aktivitätsmessung für die stimulator-kontrolle
WO2012018535A3 (en) Wellness panel
CY1111602T1 (el) ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
GB201209668D0 (en) Methods of monitoring conditions by sequence analysis
GB201021399D0 (en) Oligonucleotide probe set and methods of microbiota profiling
WO2014066913A8 (en) Health diagnostic systems and methods
DK1706019T3 (da) Dermalt fastgjort sensorindretning
ATE507771T1 (de) Blutdruckberechnungsverfahren für nichtinvasive blutdruckmessgeräte
DE112010001220A5 (de) Messsystem zur beurteilung des schluckvorgangs und/oder bestimmung der aspiration
IN2014MN02060A (el)
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
MX2010014228A (es) Metodos y productos de diagnostico del p/gf-1 acompañante.
WO2008058014A3 (en) Method and apparatus for noninvasive probe/skin tissue contact sensing
EP2509488A4 (en) METHODS AND ARRANGEMENTS FOR THE ANALYSIS, DIAGNOSIS AND MONITORING OF VOCAL STRENGTH PROCESSING BY OPTICAL COHERENCE TOMOGRAPHY
BR112014005947A2 (pt) sistema de monitoramento de uma cadeia de medida de um turborreator
BRPI1007668A2 (pt) aparelho de medição do batimento cardíaco, uso do aparelho de medição do batimento cardíaco, método, adaptado para medir o batimento cardíaco e/ou a variação do batimento cardíaco de um indivíduo
BR112015014232A2 (pt) lesão renal aguda
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2011159741A3 (en) Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
CY1114910T1 (el) Βιοδεικτης για παρακολουθηση ασθενων
AR085164A1 (es) Metodos para el analisis de la placa